Literature DB >> 15373647

Review: transfusing incompatible RBCs--clinical aspects.

G Meny1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15373647

Source DB:  PubMed          Journal:  Immunohematology        ISSN: 0894-203X


× No keyword cloud information.
  5 in total

1.  A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity.

Authors:  Hee-Jeong Youk; Ho-Yoon Ryu; Suk Won Seo; Jin Seok Kim; Yousun Chung; Hyungsuk Kim; Sang-Hyun Hwang; Heung-Bum Oh; Won-Ki Min; Dae-Hyun Ko
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

2.  Immune hemolytic anemia: a report of two cases.

Authors:  Paramjit Kaur; Sabita Basu; Ravneet Kaur; Gagandeep Kaur
Journal:  J Lab Physicians       Date:  2009-01

Review 3.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

4.  Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India.

Authors:  Suvro Sankha Datta; Somnath Mukherjee; Biplabendu Talukder; Prasun Bhattacharya; Krishnendu Mukherjee
Journal:  Adv Hematol       Date:  2015-09-06

5.  Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients.

Authors:  Frauke Ringel; Helge Schoenfeld; Said El Bali; Jalid Sehouli; Claudia Spies; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2021-12-08       Impact factor: 4.040

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.